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ABSTRACT: 
Purpose: Birth weight (BW) is associated with risk of cardiovascular (CV) disease. The 
findings form studies examined the association of BW with metabolic markers of CV risk 
were inconsistent and controversial. We examined the association of BW with insulin 
resistance and blood lipids using repeated measures up to mid-adulthood.   
Methods: Data from seven screenings of the Bogalusa Heart Study—a longitudinal 
study of cardiovascular risk factors in Bogalusa, LA, are analyzed using generalized 
estimation equations method. Participants with birth data and at least one measurement 
of study outcomes between 18-44 years of age (n=2,034) were included.  
Results: BW is inversely associated with insulin resistance, triglycerides and total 
cholesterol (P<0.01 for all). For 1-kg decrease in BW, insulin resistance increased by 
2.3 units, 95% CI = 0.7, 3.9; triglycerides by 8.7 mg/dL, 95% CI = 4.9, 12.4 and total 
cholesterol by 5.4 mg/dL, 95% CI = 1.8, 9.1. The association of body mass with adult 
blood lipids levels is weaker in persons with low- vs. normal BW.  
Conclusions: The study provides strong evidence of an inverse relationship of BW with 
adulthood cardiometabolic risk profile. Persons born with low BW are maybe less 
responsive to preventive interventions aiming at weight reduction.  
 
Key words: Birth weight; cardiovascular risk; cholesterol; insulin resistance; HOMA-IR, 
lipids, triglycerides 
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List of Abbreviations: 
BMI = Body mass index 
CV = Cardiovascular 
GEE = Generalized estimation equations 
HDL-cholesterol = High density lipoprotein cholesterol 
HOMA-IR = Homeostasis model assessment insulin resistance.  
LDL-cholesterol = Low density lipoprotein cholesterol 
SES = Socio-economic status 
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INTRODUCTION 
A large body of evidence has accumulated indicating a relationship between in 
utero growth restriction (IUGR) and the development of many disorders later in life, 
including increased insulin resistance and type 2 diabetes mellitus, hypertension, and 
adverse blood lipid profile. 1-4 According to the hypothesis of early origins of adult 
disease, adverse prenatal pressures stimulate fetal responses that permanently alter 
the “programming” of many of its physiologic systems, thus predisposing the individual 
to various diseases later in life. 5,6 Low birth weight (BW) at or near term is the most 
commonly used surrogate measure of IUGR and has been related to increased 
cardiovascular mortality, presumably due to its adverse effect on many cardiovascular 
risk factors acting later in life. 6-8 The epidemiologic evidence clearly points to an inverse 
association between BW and many hemodynamic CV risk markers, especially systolic 
blood pressure (BP) and pulse pressure (PP). 9-11 The findings are less consistent, 
however, for markers of cardiometabolic risk, such as blood lipids and lipoproteins and 
insulin resistance. 12-17 
Additionally, some authors questioned these findings citing the lack of adjustment 
for important confounders, such as socioeconomic status (SES) and lifestyle variables. 
12,18
 Others have questioned the interpretation of an effect of BW from statistical models 
concurrently relating birth- and current body mass to later CV risk factors, arguing that 
these models actually test the effect of change of body mass from birth rather than the 
effect of size at birth. 18 This notion has profound public health implications as it shifts 
the emphasis from prenatal to postnatal growth. 
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In this paper, we examine the association of BW with levels of markers of 
cardiometabolic risk (serum lipids and lipoproteins and insulin resistance), using 
repeated measurements from young to mid-adulthood that were collected by the 
Bogalusa Heart Study (BHS). To address the aforementioned points, three analytical 
approaches are used: 1) testing the associations of BW with later markers of 
cardiometabolic risk without adjusting for BMI; 2) testing the associations of BW with 
later markers of cardiometabolic risk adjusting for BMI and other important socio-
economic, behavioral and familial variables; 3) testing the association of repeated 
measures of BMI with later markers of cardiometabolic risk in persons with low BW (BW 
<2500g) vs. those with normal BW (BW ≥2500g). Modeling the association of BW and 
repeated measures of body mass with metabolic markers of CV risk allows assessing 
the effect of the total burden of the change of body mass over time on various risk 
factors. Additionally, comparing the association of BMI with the outcomes in individuals 
of low- vs. normal BW allows assessing the heterogeneity, or lack of, of the effect of 
weight gain over time on CV risk factors in the two groups.  
This study aims to reexamine the hypothesized association of low BW with an 
adverse metabolic CV risk profile later in life, while addressing the issues of adjusting 
for BMI and adequate controlling for important confounding factors such as lifestyle and 
familial variables.  
MATERIALS AND METHODS 
Participants 
The BHS is a longitudinal study following a bi-ethnic cohort (65% White, 35% African 
American) from Bogalusa, LA, to examine the natural development of CV disease. A 
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detailed description of the demographic characteristics of the community, as well as the 
overall design of the study, has been published elsewhere. 19 This study utilized data of 
seven screenings of BHS performed during participants’ early to mid-adulthood (age 
range: 18–44 years). Birth data were collected from birth certificates that were obtained 
from the Office of Health Statistics in New Orleans, LA. Of the 2,301 participants who 
were eligible to be included in this analysis, BW was available on 2,274 (98.8%) of 
them. Singletons with complete birth data and at least one measurement of markers of 
CV risk after the age of 18 years were eligible for the study (n=2,274). Birth data were 
obtained from birth certificates. Exclusion criteria included having type 1 diabetes 
mellitus (n=6); having congenital heart disease (n=4); failed to fast (n=3) and premature 
birth (n=226) leaving 2,034 participants (89.4%) who were included in this analysis. 
Informed consent was obtained from the parents during childhood screenings 
and from the participants during adulthood screenings. The study was approved by the 
institutional review board at Tulane University in New Orleans, USA. 
Procedures 
Height was measured manually to the nearest 1 mm and weight to the nearest 
0.1 kg, both as the mean of two measurements. Body mass index (BMI) was calculated 
from the formula = weight (kg)/height2 (meter). Birth weights were obtained from birth 
certificates and were then converted into kilograms (1 ounce ≈ 0.028 kg).  
All lab tests were done after overnight fasting. Serum total cholesterol and 
triglycerides measurements were performed using enzymatic procedures on Hitachi 902 
Automatic Analyzer (Roche Diagnostics, Indianapolis, IN). Low-density lipoprotein 
cholesterol (LDL-C), and high-density lipoprotein cholesterol (HDL-C) levels were 
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determined by a combination of heparin-calcium precipitation and agar-agarose gel 
electrophoresis. Plasma immunoreactive insulin levels were measured by a commercial 
radio-immunoassay kit (Phadebas, Pharmacia Diagnostics, Piscataway, NJ). Serum 
glucose level was measured as part of a multiple chemistry profile. Homeostasis model 
assessment (HOMA-IR)—calculated as [fasting insulin (µU/ml) x fasting glucose 
(mmol/L) / 22.5]—was used to measure insulin resistance. 20 The World Health 
Organization definition for low BW, <2500 g, was adopted for this study. Prematurity 
was defined as gestational age less than 37 weeks.  
Income was defined as the last self-reported annual income and was classified 
into two categories: <$45 000 and ≥$45 000. Smoking status was defined as the last 
information available about smoking and was coded into two categories: non/former-
smokers and current smokers. Alcohol consumption was defined as the last information 
available about drinking and was coded into three categories: none/less than one drink 
per week, 2–4 drinks per week, and >4 drinks per week. Family history of 
cardiovascular disease was defined as having a parent who had a heart attack, a 
stroke, a bypass surgery, or an angioplasty or who died of a heart attack or stroke. This 
variable was coded as 2 if both parents had a history of CV disease, as 1 if one parent 
had a history of CV disease, and as 0 if neither parent had a history of CV disease. 
Available information on the familial and lifestyle variables ranged from 70 percent for 
income to 99 percent for smoking status.  
Statistical analyses 
De-identified data of the outcome and the independent variables from the seven 
files pertaining to the seven Bogalusa Heart Study screenings of young adults between 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
8 
 
1988 and 2001 were linked to the file containing birth outcomes data, indexed on the 
unique ID number, and keeping the chronological order of the data. 
The outcome variables were HOMA-IR, triglycerides, total cholesterol, low 
density lipoprotein (LDL) cholesterol, or high density lipoprotein (HDL) cholesterol. The 
generalized estimation equation (GEE) method was used to analyze the data. GEE 
methods account for within-subject correlation, due to repeated measurements, and 
between-subject variation due to the individual differences among the participants. For 
each outcome, the correlation structure between the repeated measures was examined 
using Pearson’s correlation. Based on this analysis exchangeable working correlation 
matrix was defined for all models. All the dependent variables deviated from normality 
and were skewed to the right. Therefore, the inverse Gaussian distribution was selected 
for all models, resulting in much better fits to the data than the normal distribution, as 
measured by quasi likelihood under independence criterion (QIC). Two models were run 
for each outcome: the minimally-adjusted model included BW, age, sex and race as the 
independent variables, whereas the full model additionally included BMI, income, 
smoking status, alcohol drinking and parental history of CV disease. BW was entered in 
the models as a continuous variable. Age and BMI were entered as time-variant 
variables to adjust for their effect as they changed over time. To examine whether BW 
interacts with body mass, the models were rerun in those with BW <2,500 g vs. ≥2,500 
g and the coefficients of BMI in the two groups were compared. Two-tailed tests were 
used in all analyses with a significance level set to 0.01 to control for multiple testing. All 
analyses were conducted by using SPSS statistical package, version 21.0 (SPSS, Inc., 
Chicago, Illinois).      
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RESULTS: 
The mean number of screenings per subject is 2.5 (range 1-7).The sample is 65% white 
and 45% men. Table 1 shows the comparison of main birth outcomes by gender and 
race.  
Table 1. Composition and Birth Characteristics of the Study Population, by Gender and 
Ethnicity, The Bogalusa Heart Study, 1973-2001 
Race/Gender No. %a 
Mean (SD) Birth 
weight (kg) 
Low birth weight 
(<2500 g) 
Premature  
(<37 week) 
No. %b No. %b 
Caucasian 
                    Men  
                   Women 
1320 
601 
719 
65% 
30% 
35% 
3.4 (0.5) 
3.5 (0.5) 
3.4 (0.5) 
42 
14 
28 
3.2% 
1.1% 
2.2% 
59 
32 
27 
4.5% 
2.4% 
2.1% 
        
African American 
                    Men  
                   Women  
715 
315 
400 
35% 
15% 
20% 
3.1 (0.5) 
3.2 (0.5) 
3.1 (0.5) 
68 
27 
41 
9.5% 
3.8% 
5.7% 
61 
30 
31 
8.5% 
4.2% 
4.3% 
All  2035 100% 3.3 (0.5) 110 5.4% 120 5.9% 
a
 = percent of grand total; b = percent within ethnic group 
In minimally-adjusted models, BW is borderline associated with later serum 
triglycerides and total cholesterol levels (b=-5.0, p=0.03 and b=-3.4, p=0.07, 
respectively).  The results of the full models are presented in Table 2. 
Birth weight and insulin resistance 
Birth weight is inversely associated with insulin resistance. For every 1 kg 
increase in BW, HOMA-IR decreases by an average of 2.3 units. Men have lower 
HOMA-IR levels than women (b=-2.1). Individuals with lower income or higher BMI have 
higher HOMA-IR levels (b=2.5 and b=2.6, respectively). Individuals with no parental 
history of CV disease have lower HOMA-IR levels than those with a history of CV 
disease in both parents (b=-5.1). Never/ex-smokers and non-drinkers have higher 
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HOMA-IR levels than current smokers (b=2.7). Age is inversely associated with HOMA-
IR levels (b=-0.5) (Table 2).  
Birth weight and serum triglycerides  
Birth weight is inversely associated with levels of serum triglycerides. For every 1 
kg increase in BW, serum triglycerides decrease by an average of 8.7 mg/dL. Age and 
BMI are positively associated with triglycerides and (b=1.1 and b=3.8, respectively). 
Men and Caucasians have higher concentration of triglycerides than women and African 
Americans (b=4.4 and b=18.8, respectively). Non/ex-smokers have lower triglycerides 
levels than current smokers (b=-8.2).  
Birth weight and total-, LDL-, and HDL-cholesterol 
Birth weight is inversely associated with later levels of total cholesterol. For every 
1 kg increase in BW, total cholesterol decreases by an average of 5.4 mg/dL. Age and 
BMI are positively associated with total cholesterol (b=1.0 and b=1.7, respectively). 
Caucasians have higher levels of total cholesterol than African Americans (b=6.9). BW 
also is inversely associated with levels of LDL-cholesterol, but at the <0.05 significance 
level. For every 1 kg increase of BW LDL-cholesterol decreases by an average of 4.6 
mg/dL. Age and BMI are positively associated with LDL-cholesterol (b=0.3 and b=1.7, 
respectively). Men and Caucasians have higher levels of LDL-cholesterol than women 
and African Americans (b=4.3 and b=11.1, respectively). Individuals with no parental 
history of CV disease have lower levels of LDL-cholesterol than those with a history of 
CV disease in both parents (b=-3.2). BW is not independently associated with HDL-
cholesterol. Age and BMI are inversely associated with HDL-cholesterol (b=-0.1 and b=-
0.5, respectively). Men and Caucasians have lower levels of HDL-cholesterol than 
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women and African Americans (b=-7.6 and b=-6.5, respectively). Non/ex-smokers have 
higher levels of HDL-cholesterol than current smokers (b=2.7). Categories of alcohol 
drinking are inversely associated with levels of HDL-cholesterol (b=-10.6 and b=-6.3, 
respectively). 
Table 2. Regression of Metabolic Markers of Cardiovascular Risk on Birth Weight, The 
Bogalusa Heart Study, 1973-2001 
Outcome and predictors Coefficient (b) 95% confidence interval 
HOMA-IR (n=1313)   
Birth weight (Kg) -2.3 -3.9, -0.7b 
Age (years) -0.5 -0.6, -0.4b 
BMI (kg/m2) 2.6 2.4, 2.8b 
Gender 
          Men 
          Womend 
 
-2.1 
 
 
-3.8, -0.4a 
 
Parental history of CV diseasec 
          None 
          Both parentsd  
 
-5.1 
 
 
-9.8, -0.5a 
 
Smoking 
          Never/Ex  
          Current† 
 
2.7 
 
 
0.8, 4.6b 
 
Income 
          <$45,000/year 
          ≥$45,000/yeard 
 
2.5 
 
 
0.7, 4.2b 
 
Triglycerides (n=1402)   
Birth weight (kg) -8.7 -12.4, -4.9b 
Age (years) 1.1 0.8, 1.3b 
BMI (kg/m2) 3.8 3.3, 4.3b 
Gender 
          Men 
          Womend 
 
4.4 
 
 
0.5, 8.4a 
 
Race 
          Caucasian 
 
18.8 
 
15.0, 22.7b 
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          African Americand 
  
Smoking 
          Never/Ex  
          Current† 
 
-8.2 
 
 
-12.4, -4.1b 
 
Total cholesterol (n=1915)   
Birth Weight (kg) -5.4 -9.1, -1.8b 
Age (years) 1.0 0.8, 1.1b 
BMI (kg/m2) 1.7 1.5, 2.0b 
Race 
          Caucasian 
          African Americand 
 
6.9 
 
 
3.2, 10.6a 
 
LDL-cholesterol (n=1346)   
Birth weight (kg) -4.6 -8.2, -0.9a 
Age (years) 0.3 0.2, 0.5b 
BMI (kg/m2) 1.7 1.4, 1.9b 
Gender 
          Men 
          Womend 
 
4.3 
 
 
1.0, 7.6a 
 
Race 
          Caucasian 
          African Americand 
 
11.1 
 
 
7.5, 14.8b 
 
Parental history of CV diseasec 
          None 
          Both parentsd  
 
-3.2 
 
 
-9.0, 2.7a 
 
HDL-cholesterol (n=1769)   
Birth weight (kg) 0.2 -0.8, 1.3 
Age (years) -0.1 -0.2, -0.0a 
BMI (kg/m2) -0.5 -0.6, -0.4b 
Gender 
          Men 
          Womend 
 
-7.6 
 
 
-8.6, -6.7b 
 
Race 
          Caucasian 
          African Americand 
 
-6.5 
 
 
-7.9, -5.2b 
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Smoking 
          Never/ex  
          Currentd 
 
2.7 
 
 
1.7, 3.7b 
 
Drinking 
          None <1 drink/week 
          2-4 drinks/week 
          >4 drinks/weekd 
 
-10.6 
-6.3 
 
 
-13.9, -7.2b 
-10.0, -2.5b 
 
BMI = body mass index; CI = confidence interval; HDL-cholesterol = High density lipoprotein 
cholesterol; HOMA-IR = homeostasis model assessment insulin resistance; LDL-cholesterol = 
Low density lipoprotein cholesterol.  a p<0.05, b p<0.01, c = p-value is for the trend, d = reference 
category. Models are adjusted for age, BMI, gender, race, income, smoking status, alcohol 
drinking and parental history of CV disease. The differences in the actual numbers included in 
each model are due to missing values on covariates 
  
To assess whether the effect of BW on the outcomes is homogenous across its 
range, we repeated the analysis in subgroups with BW below and above 3.3 kg (50% 
percentile) for the three significant outcomes (HOMA-IR, triglycerides and total 
cholesterol). The coefficients of BW in both subgroups were similar and in the same 
direction to those obtained from the total sample (HOMA-IR: b=-4.1 and -2.7; 
triglycerides: b=-14 and -6.7; total cholesterol: b=-2.8 and -5.6, for BW ≤ 3.3 kg and BW 
> 3.3 kg, respectively, p<0.05 for all).  
To assess whether BW interacts with later BMI on cardiometabolic risk profile, 
the interaction term (BW x BMI) was tested in the full model for all the outcomes. With 
the exception of HOMA-IR, the interaction was significant in all models (p<0.01 for all). 
To evaluate this interaction, the effect of BMI on cardiometabolic risk outcomes was 
compared between the subgroups of low BW (<2,500 g) vs. normal BW (≥2,500 g). The 
comparison shows that, with the exception of insulin resistance, the coefficient of BMI is 
2-4 times larger in the normal BW group compared to the low BW one (Table 3).  
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Table 3. Comparison of the Association of BMI on Metabolic Markers of Cardiovascular Risk in 
Persons with Low vs. Normal Birth Weight, The Bogalusa Heart Study, 1973-2001 
Outcome 
Coefficient of BMI (95% CI)a 
<2,500 g                          ≥2,500 g 
HOMA-IR 2.7 (1.2, 4.1) 2.6 (2.4, 2.8) 
Triglycerides (mg/dL) 2.3 (0.3, 2.9) 4.1 (3.5, 4.5) 
Total cholesterol (mg/dL) 0.8 (0.0, 1.8) 1.8 (1.5, 2.0) 
LDL-cholesterol (mg/dL) 0.6 (-0.1, 1.3) 1.7 (1.4, 1.9) 
HDL-cholesterol (mg/dL) -0.1 (-0.4, 1.7) -0.5 (-0.6, -0.4) 
BMI = body mass index; CI = confidence interval; HDL-cholesterol = High density lipoprotein 
cholesterol; HOMA-IR = homeostasis model assessment insulin resistance; LDL-cholesterol = 
Low density lipoprotein cholesterol. a = Adjusted for age, gender and race 
 
DISCUSSION 
In this population, low BW is associated with an adverse metabolic profile later in 
adulthood that is characterized by higher levels of insulin resistance, triglycerides, and 
total- and LDL-cholesterol. For each 1 kg (2.2 lb) lower BW, insulin resistance, 
triglycerides, total- and LDL-cholesterol increased by 2.3 units, 8.7 mg/dL, 5.4 mg/dL 
and 4.6 mg/dL, respectively. Moreover, comparing the relationship of BW with these 
outcomes in individuals below and above the 50% percentile of BW (3.3 kg) shows that 
the effects of BW on later HOMA-IR and triglycerides levels tend to be stronger in the 
lower BW group, while the opposite is true for total cholesterol. These results agree with 
findings from other studies which found an inverse association of BW with insulin 
resistance, 21-23 and with blood lipids. 24-26 These findings emphasize the need for 
optimum nutrition and medical care during pregnancy.  
The finding that BW is inversely associated with insulin resistance later in life 
agrees with the observed association of low BW with increased risk of type 2 diabetes 
that is consistently observed in studies in different populations 4,27,28.  Many studies 
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found that the highest risk of increased insulin resistance and diabetes is conveyed by a 
combination of low BW with an accelerated weight gain early in life (catch up growth). 
23,27,29
 In this study, BMI was analyzed as a time-variant variable, i.e., the models 
adjusted for the trajectory of BMI change over time. BMI change significantly predicts 
later HOMA-IR, but its effect is similar in individuals with low- vs. normal BW (table 3). 
Therefore, and unlike the case of BW with early weight gain, our data provides no 
evidence of an interaction between BW and later change in body mass on risk of insulin 
resistance. In this model, the finding of an inverse association of age with insulin 
resistance was unexpected. This may be because age-HOMA-IR relation is non-linear. 
Another possibility is that this could be a chance finding because when the analysis was 
restricted to individuals older than 25 years of age the findings for all the outcomes 
remained essentially the same and the coefficient of age on HOMA-IR became positive 
but statistically insignificant. 
The inverse association of BW with serum triglycerides is one of the most 
consistently reported finding.13 The finding of a strong inverse association of BW with 
serum triglycerides levels later in life provides additional evidence of an adverse role of 
low BW on insulin resistance since increased triglycerides levels is one of the criteria for 
diagnosing metabolic syndrome. This finding also has important implications for public 
health, especially in African Americans, given the ease of measuring this risk factor, its 
association with metabolic syndrome, and its high prevalence, along with low BW, 
among African Americans. 30,31 
The inverse associations of BW with total- and LDL-cholesterol levels agree with 
findings from many other studies. 23,32,33 However, the association of BW with later 
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cholesterol levels is also controversial, as several studies reported either a very small or 
no effect of BW. 12,13,25 Some studies reported this association in men only. 26,33 Our 
results, using repeated measurements, support the inverse association between BW 
and cholesterol levels.  
Table 3 shows that the effect of body mass (as BMI) on blood lipids is less 
pronounced in persons of low BW; that is the influence of body mass in determining 
adulthood lipids levels is smaller in persons with low BW. One explanation could be that 
other, low BW-related mechanisms play a role in determining lipids levels in persons 
born small in size. That is, the heterogeneous effect of body mass on lipid levels 
between those of low- vs. normal BW indicates that starting lower on the continuum of 
body size from birth to adulthood involves different mechanisms affecting later lipids 
levels. This suggests that in persons with low BW interventions targeting body weight 
may produce smaller improvements in blood lipids than that expected in persons with 
normal BW, which reemphasizes the role of prenatal growth and, consequently the 
importance of adequate health care during pregnancy.      
In this population, parental history of CV disease independently predicts insulin 
resistance and total cholesterol in adulthood. The association is inverse and graded, but 
the difference between one vs. both parents is not significant. The important implication 
for risk-classification is that individuals born small with a familial history of CV disease 
have a greater risk of CV disease.   
Some authors pointed out the small effect of low BW on metabolic markers of CV 
disease risk implying little or no clinical significance. 12,13,26 Taken individually, these 
changes may not be clinically significant. However, these differences are in the 
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population average. Small changes on the population average carry more overall effect 
than individual differences. Moreover, BW affects many hemodynamic and metabolic 
markers of CV risk—effects that start early and continue throughout life. 8,9,25,26 The long 
duration and the combined impact of those multiple risk factors could explain the 
observed association of low BW with increased CV morbidity and mortality. 7,34  
This study has some limitations: there are no data on early postnatal growth to 
assess its effect on the study’s outcomes, 35 which we found previously in a small 
sample to be associated with blood pressure 36; only the last available information on 
smoking and drinking habits is used to adjust for their effects, which may not reflect the 
real burden of these factors on the outcomes; the number of persons with low BW is 
small, which means that the subgroup analysis described in Table 3 must be interpreted 
with caution. This study has several strengths: an adequate sample size; repeated 
measures of the outcomes spanning a long period of time; the adjustment for important 
confounders; the ascertainment of BW from birth certificates, and the use of advanced 
analytical methods.   
CONCLUSIONS 
Taken together, these findings provide additional evidence of the role of prenatal 
factors in predisposing the individual to diabetes and coronary heart disease later in life 
and, consequently, reemphasize the need for proper prenatal care. Additionally, timely 
and more intensive preventive programs, that specifically target insulin resistance and 
blood lipids, are needed in persons born small in size 
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